Related Experiment Video
Updated: May 5, 2026

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
Published on: July 12, 2018
[The Proteus syndrome: a rare cause of pulmonary emphysema]
C Launois1, H Vallerand, J-M Perotin
1Inserm UMRS 903, service des maladies respiratoires, hôpital Maison-Blanche, CHU de Reims, 45, rue Cognacq-Jay, 51092 Reims cedex, France.
Insights
Proteus syndrome, a rare genetic disorder from AKT1 mutations, can cause severe pulmonary emphysema. This case highlights a potential link between Proteus syndrome and lung disease, suggesting shared pathways with lymphangioleiomyomatosis.
Area of Science:
- Genetics
- Pulmonology
- Oncology
Background:
- Proteus syndrome is a rare genetic disorder characterized by tissue overgrowth, linked to somatic mosaic activating mutations in the AKT1 oncogene.
- This condition involves abnormal development of bone, connective, and adipose tissues.
Observation:
- A 25-year-old male with Proteus syndrome, diagnosed at 6 months, presented with asymmetric limb overgrowth and respiratory failure.
- He developed severe bullous pulmonary emphysema, predominantly on the left, with mediastinal deviation, following a bronchopulmonary infection.
Findings:
- The patient exhibited mild hypoxemia and severe airflow limitation with hyperinflation post-infection.
- Pulmonary function tests revealed significantly reduced FEV1 and elevated residual volume, indicative of obstructive lung disease.
Implications:
- Proteus syndrome is an exceptionally rare cause of pulmonary emphysema.
- The exact pathophysiology of emphysema in Proteus syndrome remains unclear.
- It is hypothesized that AKT1 activation may play a role in pulmonary cyst development and emphysema, similar to lymphangioleiomyomatosis.
Introduction:
The Proteus syndrome is a rare genetic disease which is characterized by the overgrowth of tissues, especially bone, connective and adipose tissue. This condition is related to a somatic mosaic activating mutation in the AKT1 oncogene.
Case Report:
We report the case of a 25-year-old man, diagnosed with the Proteus syndrome at the age of 6 months. He exhibited an asymmetric overgrowth of the extremities leading to bilateral amputation of the legs at the age of 10 years. He was hospitalized for acute respiratory failure due to a bronchopulmonary infection. Severe bullous pulmonary emphysema, predominantly on the left, with mediastinal deviation, was diagnosed. The patient recovered with antibiotics. An assessment 2 months later revealed mild hypoxaemia (PaO2=75 mmHg) and severe airflow limitation (FEV1=1260 mL [28% th.], FEV1/V C=69%) with hyperinflation (TLC=7840 mL [107% th.], RV=6010 mL [253% th.]).
Conclusion:
The Proteus syndrome is a very rare cause of pulmonary emphysema. The pathophysiology of emphysema in this syndrome is unknown. It can be hypothesized that the development of pulmonary cysts leading to emphysema may share the same AKT1 activation pathway with lymphangioleiomyomatosis.
Related Concept Videos
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

